MedPath

Randomised trial of anti-emetics in pre-hospital care (The RAPS Trial)

Phase 4
Conditions
ausea and vomiting
Nausea and vomiting
Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)
Registration Number
ACTRN12608000576325
Lead Sponsor
St John Ambulance - Western Australian Ambulance Service
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
450
Inclusion Criteria

All patients managed by the ambulance service who are either actively vomiting or have a nausea score greater or equal to 4

Exclusion Criteria

Age less than 18
Received trial agents in the previous 24hours
Pregnant or possibly pregnant
Weight less than 60kg
Altered conscious level (Glascow Coma Score < 15)
Refuses intramuscular injection
No consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in nausea and vomiting. <br>Active vomiting will be assessed by direct observation of the patient. <br>Nausea will be assessed using a verbal analogue scale (Rating scale of 1 - 10).[On arrival at hospital Emergency Departments]
Secondary Outcome Measures
NameTimeMethod
Significant adverse events will be assessed through either direct observation by the attending ambulance paramedic or observed / reported by clinical staff at the receiving hospital.[On arrival at hospital Emergency Departments]
© Copyright 2025. All Rights Reserved by MedPath